Correlation Between UTI Asset and Akums Drugs
Specify exactly 2 symbols:
By analyzing existing cross correlation between UTI Asset Management and Akums Drugs and, you can compare the effects of market volatilities on UTI Asset and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UTI Asset with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of UTI Asset and Akums Drugs.
Diversification Opportunities for UTI Asset and Akums Drugs
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between UTI and Akums is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding UTI Asset Management and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and UTI Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UTI Asset Management are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of UTI Asset i.e., UTI Asset and Akums Drugs go up and down completely randomly.
Pair Corralation between UTI Asset and Akums Drugs
Assuming the 90 days trading horizon UTI Asset Management is expected to under-perform the Akums Drugs. In addition to that, UTI Asset is 1.12 times more volatile than Akums Drugs and. It trades about -0.2 of its total potential returns per unit of risk. Akums Drugs and is currently generating about -0.2 per unit of volatility. If you would invest 55,130 in Akums Drugs and on November 28, 2024 and sell it today you would lose (5,980) from holding Akums Drugs and or give up 10.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
UTI Asset Management vs. Akums Drugs and
Performance |
| Timeline |
| UTI Asset Management |
| Akums Drugs |
UTI Asset and Akums Drugs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with UTI Asset and Akums Drugs
The main advantage of trading using opposite UTI Asset and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UTI Asset position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.| UTI Asset vs. ROUTE MOBILE LIMITED | UTI Asset vs. SBI Life Insurance | UTI Asset vs. CSB Bank Limited | UTI Asset vs. RBL Bank Limited |
| Akums Drugs vs. Silgo Retail Limited | Akums Drugs vs. Paramount Communications Limited | Akums Drugs vs. Reliance Communications Limited | Akums Drugs vs. Shyam Telecom Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |